🇺🇸 FDA

Company profile · Sponsor

Kailera

Kailera Therapeutics

KLRA · NYSE pharma WALTHAM, MA, USA
Pipeline
7
Drugs
0
Patents
0

Quick answer

Kailera (KLRA) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker KLRA
Exchange NYSE
Company type pharma
Headquarters WALTHAM, MA, USA
SEC CIK 0002096997

Pipeline (7)

Search pipeline →

  1. Identical to kai-9531 solution for injection without active drug, KAI-9531, KAI-9531, KAI-9531

    Kailera

    Obesity

    phase 3 small molecule active

    1 trial

  2. KAI-9531

    Kailera

    Obesity

    phase 3 small molecule active

    3 trials

  3. KAI-9531

    Kailera

    Obesity With Diabetes

    phase 3 small molecule active

    1 trial

  4. KAI-9531, KAI-9531, Identical to kai-9531 solution for injection without active drug, KAI-9531

    Kailera

    Obesity

    phase 3 small molecule active

    1 trial

  5. Wegovy 0.25 mg FlexTouch solution for injection in pre-filled pen, Wegovy 0.5 mg FlexTouch solution for injection in pre-filled pen, Wegovy 1.7 mg FlexTouch solution for injection in pre-filled pen, Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, Wegovy 1 mg FlexTouch solution for injection in pre-filled pen, KAI-9531, KAI-9531

    Kailera

    Obesity

    phase 3 small molecule active

    1 trial

  6. KAI-7535

    Kailera

    Obesity

    phase 2 small molecule active

    2 trials

  7. KAI-9531

    Kailera

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is Kailera?

Kailera (KLRA) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Kailera sponsor?

We track 7 ClinicalTrials.gov-linked programs for Kailera, including Identical to kai-9531 solution for injection without active drug, KAI-9531, KAI-9531, KAI-9531 and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Kailera company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.